NCT01477463View on ClinicalTrials.gov

Pilot Trial to Evaluate the Effect of Vitamin D on Melanocyte Biomarkers

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Melanoma, Skin
Interventions
DRUG

Vitamin D3

4,000 IU oral vitamin D3

DRUG

placebo and vitamin D

Trial Locations (1)

94305

Stanford University Cancer Institute, Palo Alto

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

lead

Stanford University

OTHER

NCT01477463 - Pilot Trial to Evaluate the Effect of Vitamin D on Melanocyte Biomarkers | Biotech Hunter | Biotech Hunter